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Abstract 
Background: Estimation of progression in Parkinson’s disease (PD) is useful to guide 
clinical decisions and to enable patients to plan and manage their life with PD. Rapid eye 
movement (REM) sleep behavior disorder (RBD) and REM sleep without atonia (RWA) are 
recognized as early harbingers of neurodegeneration and may precede motor symptoms by 
years. However, their impact on motor progression remains elusive.   
Methods: We retrospectively analyzed polysomnographic and clinical data of 59 PD 
patients, grouping them into patients with RBD (n=15), RWA (n=22) and those with normal 
muscle atonia (n=22). We compared the three groups with regard to motor progression, 
defined as changes in Unified Parkinson’s Disease Rating Scale (UPDRS) III values per 
year, and selected PD specific characteristics. 
Results: Motor disability at first visit and time interval between first and last visits were 
similar between groups. We observed a significantly faster motor progression in PD patients 
with RBD and RWA than in those with preserved REM sleep atonia.   
Conclusion: Our findings suggest that impaired muscle atonia during REM sleep might 
represent a marker of faster motor progression in PD.   
 
  
 
  
Introduction 
Several prognostic factors including postural instability, predominance of type and body side 
of motor features at disease onset impact the evolution of motor and non-motor symptoms in 
Parkinson’s disease (PD) [1-4]. In the first description of REM sleep behavior disorder (RBD) 
by Schenck et al. in 1986, a close link to neurodegenerative disorders was already reported 
[5]. RBD consists of two features: loss of atonia during REM sleep, so called REM sleep 
without atonia (RWA) and acting out of dreams, most often of violent content [6]. In this line, 
it would be important to know whether RBD and RWA not only heralds the occurrence of PD 
[7], but also predicts the pace of disease progression. As RBD is associated with higher 
doses of levodopa, occurrence of hallucinations and higher burden of autonomic failure [8], 
RBD may reflect a more widespread neurodegeneration. Still, longitudinal studies to examine 
the association between RBD and PD progression are rare. Only one study investigated the 
predictive value of RBD on motor disability in PD over time [9]. Thirty-nine PD patients with 
interview-based diagnoses of RBD were compared to 22 PD patients without RBD, and 
significantly faster evolution of motor disability or of several non-motor symptoms was not 
found [9]. Therefore, our goal was to analyze the influence of polysomnography (PSG)-
proven RBD and REM sleep without atonia (RWA) on progression of motor disability. 
Methods 
We retrospectively analysed 104 consecutive PD patients of our outpatient movement 
disorder unit who underwent video-polysomnography (PSG) from 2003-2010 for diagnostic 
purposes (i.e. for the assessment of RBD, sleep apnea, or periodic limb movements).. We 
excluded patients with deep brain stimulation (n=4), incomplete follow-up data (n=38) and no 
REM sleep in PSG (n=3). All patients accepted to provide their data for research purposes by 
written informed consent; ethical approval for retrospective analyses was waived. 
Clinical information included disease type (i.e. tremor-dominant vs. akinetic-rigid phenotype 
or equal distribution [2]), predominantly affected body side, motor disability and disease 
severity as measured by UPDRS part III on medication (during outpatient visits) and Hoehn 
& Yahr scale, respectively, and calculation of total levodopa equivalent doses (LED) [10]. 
Polysomnographic diagnosis of RBD and RWA was performed along international 
recommendations [11]: We used following references values: a 30-second epoch was scored 
as tonic if chin EMG activity was present for more than 50% of the epoch; phasic epochs 
were scored in response of 2-second mini-epochs (within 30-second REM sleep epoch) with 
bursts of EMG activity; RWA was ascertained if tonic chin EMG density was greater than 
approximately 30% and / or a phasic chin EMG density was greater than approximately 15% 
of total REM sleep time was assessed as REM sleep without atonia (RWA). RWA with 
complex movements or vocalization as assessed by time-locked video was defined as 
manifest RBD. All patients exhibiting one or more episodes with RBD during PSG were here 
defined as patients with RBD; patients with REM sleep atonia abnormalities but without any 
episode of complex movements or vocalization were classified as patients with RWA. 
We used SPSS (version 21) for statistical analyses. Motor progression was calculated as 
difference of UPDRS III values between first and last visits, divided by the number of years 
between these visits [2]. To calculate differences between groups, we applied one-way 
ANOVA with trend analysis on significant results or Kruskal-Wallis tests for multiple groups, 
Student’s t-test or Mann-Whitney tests for two groups, and Chi-Square tests when 
appropriate. Trend analysis was performed with -1.5, 0.5 and 1 as coefficients to enhance 
differentiation between preserved REM atonia to any type of altered REM sleep tonus and to 
include all three groups. Stepwise multiple linear regression analysis was performed for 
multivariate analysis (dependent variable: total change of UPDRS III per year; independent 
variables: REM sleep tonus (preserved, RWA or, RBD), sex, age, age at onset, predominant 
side and motor type of symptoms, disease duration, Hoehn & Yahr scale, UPDRS III, length 
of interval between first and last visit, change of total LED per year, and total LED at 
baseline).  
  
Results 
Demographics, disease duration, motor disability and dopaminergic treatment were similar in 
PD patients with RBD, RWA and preserved REM atonia (Table 1). While UPDRS III scores 
at first visit were similar, group comparisons revealed significant differences in motor 
progression after mean follow-up of 2.5±1.5 years, with most pronounced decline of motor 
function in PD patients with RBD, intermediate decline in those with RWA and almost no 
deterioration in those with preserved REM atonia (Figure 1). Trend analysis revealed a 
significant trend on UPDRS III at last visit and on motor progression per year from preserved 
REM atonia to RWA to RBD (p = 0.015 and p = 0.014, respectively). Similarly, linear 
regression analysis confirmed that presence of RBD or RWA was strongly associated with 
UPDRS III increment (β = 0.302, p = 0.015, co-associate: change of total LED per year: β = 
0.263, p = 0.003). 
When analyzing only two groups, i.e. those patients with RWA or RBD against those with 
normal REM, this finding did not change (Table 1). In linear regression analysis, incidence of 
altered REM sleep tonus was again the strongest associate with total change of UPDRS III 
per year (β = 0.302, p = 0.015, co-associates: age: β = 0.244, p = 0.046 and change of total 
LED per year: β = 0.282, p = 0.023). 
Discussion 
Our study in 59 PD patients suggests that both RWA and RBD predict faster deterioration of 
motor function. Our results are not in accordance with the earlier report of Lavault et al. [9]. 
Both studies included similar numbers of patients, but RBD was differently assessed: by 
history in the previous study, and by video-polysomnography in this report. In our analysis, 
patients with RWA elicit a faster motor worsening. As altered REM sleep in patients with 
RWA is not detected as in an interview based study, differences in classification may explain 
the divergent outcomes in these two studies.  
The observed disparity of motor progression is difficult to explain, because the 
neuroanatomical substrates for loss of REM atonia and motor symptoms in PD do not 
overlap. Animal studies and few observations in humans indicate that the locus subcoeruleus 
sublaterodorsal nucleus, the precoeruleus complex and the magnocellular reticular formation 
regulate atonia in REM sleep [13], while dysfunction of basal ganglia circuitries is believed to 
underlie motor problems in PD. Thus, RBD and RWA might reflect more widespread, more 
pronounced alpha-synuclein neuropathology, in terms of a propagation of adjacent brainstem 
nuclei [7]. 
Our study has several limitations. First of all, the number of included patients is low and 
follow-up times were rather short. Still, despite these quantitative limitations, the finding of 
accelerated progression in REM-altered PD patients was significant. Furthermore, the setting 
was retrospective, and indication for PSG was done on clinical purpose. Thus, UPDRS III 
examinations off and on medication were not performed, and an inclusion bias cannot be 
ruled out. The use of additional limb EMG instead of chin EMG only would be more accurate 
to detect RWA [13]; however, due to the retrospective design of our study, it was not 
available in all patients. We only performed one night of PSG which might impair the 
detection rate of dream enactment during RWA to define RBD as there is a considerable 
inter-night variance in RBD [14]. We therefore also performed statistical analysis of only two 
groups (with and without REM sleep tonus abnormalities) which revealed similar results. 
Nevertheless, positive trend analysis points to a significant difference between solely RWA 
and manifest RBD concerning motor progression in PD. This should, however, be confirmed 
by larger studies.  Altogether, for a definite answer whether or not RBD impacts motor 
progression, the best of the 2 studies should be combined in a new study, particularly with a 
prospective setting in a larger number of patients, longer follow-up intervals, measurements 
of UPDRS III in the off state and of RWA/RBD by polysomnography with additional limb 
EMG, and maybe even nuclear medicine measurements as marker of neurodegeneration 
could be considered. 
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Formatiert: Französisch (Schweiz)
Table 1 
Demographic and clinical characteristics of 59 patients with Parkinson’s disease, grouped 
according to abnormalities of REM sleep muscle tone. RBD=REM sleep behaviour disorder. 
RWA=REM sleep without atonia. UPDRS=Unified Parkinson’s Disease Rating Scale. 
LED=Levodopa equivalent dose. 
 
 
  
       
 
Preserved 
REM atonia RWA RBD p 
RWA or 
RBD p 
n 15  22 22  44  
       
Sex, female (%) 47 46 46 ns 46 ns 
Age (years) 66±11 64±10 69±5 ns 67±8 ns 
Disease duration years 7.5 ± 6.0 8.4 ± 6.7 9.7 ± 6.8 ns 9.1 ± 6.7 ns 
Hoehn & Yahr (mean) 2.2 ± 0.7 2.4 ± 0.8 2.4 ± 1.0 ns 2.4 ± 0.9 ns 
Left side more affected (%) 53 72 50 ns 61 ns 
Tremor-dominant PD (%) 33 27 36 ns 32 ns 
 
First visit: 
 
UPDRS III (mean) 
 
 
 
21± 6 
 
 
 
20±7 
 
 
 
21±8 
 
 
 
ns 
 
 
 
21±7 
 
 
 
ns 
Dyskinesia (%) 14 41 41 ns 41 ns 
Total LED (mg/d) 652±532 753±465 798±363 ns 776±415 ns 
 
Last visit: 
       
Interval first-last visit (years) 2.1±1.0 2.7±1.9 2.7±1.2 ns 2.7±1.6 ns 
UPDRS III (mean) 22±7 26±10 32±10 0.016 29±10 0.034 
Total LED (mg/d) 730±437 826± 434 886±410 ns 856±418 ns 
 
Motor progression: 
 
UPDRS III / year (mean) 
 
 
 
0.1±3.6 
 
 
 
3.0±5.6 
 
 
 
4.3±4.9 
 
 
 
0.04 
 
 
 
3.7±5.2 
 
 
 
0.018 
Figure 1 
Accelerated motor decline in patients with Parkinson’s disease with REM sleep tonus 
abnormalities. RBD=REM sleep behaviour disorder. RWA=REM sleep without atonia. 
UPDRS=Unified Parkinson’s Disease Rating Scale. *=p<0.05 for group comparison. 
 
 
 
 
 
 
 
